Single facility prospective study on fertility-preserving treatment by cryopreservation of ovarian tissue and autologous ovarian tissue transplantation for CAYA generation patients on the premise of treatment likely to abolish gonad functio

Not Applicable

Recruiting

• Conditions: 1. Hematopoietic malignancy (Hodgkin' s lymphoma, etc.) 2. Cervical cancer (Squamous cell carcinoma) 3. Breast cancer 4. Rare cancer other than hematopoietic malignancy 5. Hematological diseases requiring hematopoietic cell transplantation (Aplastic anemia, etc.) or autoimmune diseases

• Registration Number: JPRN-UMIN000039717
• Lead Sponsor: Mie University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-05
• Last Update Posted: 17 October 2023
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with a high probability of metastasis of the original disease to the ovary 2) Patients with obvious infections 3) Patients with severe uncontrollable complications 4) Patients whose doctor judges that this study is inappropriate for participation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Birth rate in cryopreserved ovarian tissue autotransplant population